AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Gilead Sciences
Support Services

Products covered:

Emtriva (emtricitabine)
Hepsera (adefovir)
Viread (tenofovir)
Vistide (cidofovir) 1-800-226-2056




Contact
Program Eligibility
The patient must meet the following criteria to qualify:
  • Must be a U.S. citizen.
  • Has no health insurance or no prescription coverage.
  • Not eligible for Medicaid, ADAP, or other drug assistance programs.
  • According to the program: "Income criteria is very generous".
Enrollment Process
Patients or doctors can call to get an application. The completed application needs to be faxed back to the program to start enrollment.
Re-Application
After acceptance into the program re-enrollment is not necessary for 12-months.
Comments
It will take approximately 2-days to have the application form completely processed. After the 2-day turnaround the drug will be sent out overnight.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network